Dazhao Mi

机构：East China Normal University · ORCID：0000-0002-1385-8917

发表论文 15 篇 · 总被引 353 次 · h-index 10

代表论文

In vivo target protein degradation induced by PROTACs based on E3 ligase DCAF15 (2020 · Signal Transduction and Targeted Therapy · 被引 90)
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design (2023 · European Journal of Medicinal Chemistry · 被引 48)
Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin (2019 · Journal of Medicinal Chemistry · 被引 37)
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer (2024 · Journal of Experimental & Clinical Cancer Research · 被引 32)
Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (2023 · Cancer Letters · 被引 31)
Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo (2024 · European Journal of Medicinal Chemistry · 被引 27)